Catherine Stehman-Breen - Jun 9, 2023 Form 4 Insider Report for Tenaya Therapeutics, Inc. (TNYA)

Role
Director
Signature
/s/ Jennifer Drimmer Rokovich, Attorney-in-Fact
Stock symbol
TNYA
Transactions as of
Jun 9, 2023
Transactions value $
$0
Form type
4
Date filed
6/12/2023, 08:34 PM
Previous filing
Jun 12, 2023
Next filing
May 24, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TNYA Stock Option (Right to buy) Award $0 +29.5K $0.00 29.5K Jun 9, 2023 Common Stock 29.5K $7.12 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Option granted pursuant to the Tenaya Therapeutics, Inc. 2021 Equity Incentive Plan. Option will vest in full upon the first anniversary of the date of grant or, if earlier, the day immediately before the date of the next annual meeting of stockholders that occurs after the grant date, subject to the Reporting Person continuing to be a service provider to the Issuer through each applicable vesting date.